Interestingly, Liang et al. used nanoparticles loaded with small interfering RNA (siRNA) to downregulate the expression of the pro-oncogenic factor Sphk2 in HCC cells to reduce exosomal miR-21, thus decreasing tumor cell migration and exosome-mediated tumorigenic function. Here, SPHK2 is linked to hepatocellular carcinoma.